Inherited breast cancer: An emerging picture

Clinical Genetics

Volumn 54, Issue 6, 1998, Pages 447-458

  Welcsh, Piri L ^a   Schubert, Elizabeth L ^a   King, Mary Claire ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Breast cancer; Epidemiology; Molecular biology

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; FAMILIAL CANCER; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; ONCOGENE; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0032408209     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb03764.x     Document Type: Review

References (17)

1. American Cancer Society. Cancer Facts and Figures. Atlanta. GA: ACS, 1994.
2. Broca P. Traite des Tumeurs. Paris: P Asselim, 1886: 1889.
3. Hall JM, Lee MK, Newman B, Morrow JE, Andersen LA, Huey B, King MC. Linkage of early onset familial breast cancer to chromosome 17q21. Science 1990: 250: 1684-1689.
4. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA. Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCAI. Science 1994: 266: 66-71.
5. Wooster R, Bignell G, Lancaster I, Swift S, Seal S, Mangion I, Collins N, Gregory S, Gumbs C, Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995: 378: 789-792. [Published erratum appears in Nature 1996: 379(6567): 749].
6. Wooster R, Bignell G, Lancaster I, Swift S, Seal S, Mangion I, Collins N, Gregory S, Gumbs C, Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995: 378: 789-792. [Published erratum appears in Nature 1996: 379(6567): 749].
7. Tavtigian SV, Simard J, Rommens J. Couch F, Shattuck-Eidens D, Neuhausen S et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996: 12: 333-337.
8. Collins N, McManus R, Wooster R, Mangion J, Seal S. Lakhani SR, Ormiston W, Daly PA, Ford D, Easton DF et al. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 1995: 10: 1673-1675.
9. Smith SA, Easton DF, Evans DO, Ponder BA. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 1992: 2: 128-131.
10. Newman B, Austin MA, Lee M, King MC. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 1988: 85: 3044-3048.
11. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991: 48: 232-242.
12. Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P. Shugart YY, Goldgar D, Narod SA, Lynch HT. Lenoir GM. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer susceptibility genes? Am J Hum Genet 1997: 60: 486-495.
13. Schubert EL, Lee MK, Mefford HC, Argonza RH. Morrow JE, Hull J. Dann JL, King MC. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families lose cancer is not attributable to BRCA1 or BRCA2. Am J Hum Genet 1997: 60: 1031-1040.
14. Ford D, Easton DF, Stratton M, Narod S, Goldgar D. Devilee P et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998: 62: 676-689.
15. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994: 343: 692-695.
16. Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers, (submitted 1998).
17. Puget N, Torchard D, Serova-Sinilnikova OM, Lynch HT, Feunteun J, Lenoir GM, Mazoyer S. A 1-kb Alu-mediated germline deletion removing BRCA1 exon 17. Cancer Res 1997: 57: 828-831.